Section 4: Antimicrobial Stewardship Program Logistics (Fellows)
Content in this section is available through 2 activities.
|“Shortage Mitigation of Antibiotics in Real Time (SMART)” Exercise|
The first activity is an antibiotic shortage simulation exercise entitled “Shortage Mitigation of Antibiotics in Real Time (SMART)”.
You should prepare for the shortage exercise by researching the SMART preparation questions. Faculty can distribute the questions and provide a brief primer on the activity or you can access the questions and brief primer via the eLearning module.
Ideally, several hours to a week later, faculty will lead a small group exercise while working through the eLearning module as a group. If faculty resources are not available, you are welcome to view/listen to the pre-recorded "SMARTcast Exercise", recorded at IDWeek 2018.
|"Reflective Observation, Brief Interview, and Notation (ROBIN)" Exercise|
The second activity in this section is the "Reflective Observation, Brief Interview, and Notation (ROBIN) exercise".
For this component of the curriculum, you will prepare for the exercise with a brief primer on medical staff governance and activity instructions using either the eLearning module or PDF documents distributed by faculty. After meeting with your faculty champion, you will plan to either attend 2 leadership activities (such as AS or Infection Prevention meetings) or interview 2 medical staff leaders. Next, you'll then prepare a one-page write up of your impressions.
Fellows/Trainees in Antimicrobial Stewardship Training Program
Upon completion of this section, you will be able to:
- Describe key steps in establishing an ASP
- Identify multidisciplinary collaborations necessary for the success of an ASP
- Describe how to implement the core elements of ASPs into practice
- Recognize regulatory and reporting aspects of ASPs
- Describe AS quality improvement and patient safety activities
- Recommend strategies for responding to antimicrobial shortages
AS Curriculum Workgroup COI Summary Reviewed April 2017 by Rachel Simmons, MD No conflicts found
|Name||Individual's Role in Activity||Name of Commercial Interest||Nature of Relationship|
|Abbo, Lillian||Workgroup member||Pfizer Brazil||Honoraria|
|Advani, Sonali||Workgroup member||Nabriva Therapeutics||Advisory/Consultant Role|
|Amstrong, Wendy||Workgroup member||None|
|Barsoumian, Alice||Workgroup member||None|
|Beeler, Cole||Workgroup member||None|
|Bystritsky, Rachel||Workgroup member||None|
|Cherabuddi, Kartik||Workgroup member||Gatorade||Start - up Research Fund|
|NIH (Medimmune)||Research Grant|
|Cohen, Seth||Workgroup member||None|
|Hamilton, Keith||Workgroup member||None|
|Ince, Dilek||Workgroup member||Ansun Pharma||Research Grant|
|Justo, Julie Ann||Workgroup member||None|
|Luther, Vera||Workgroup member||None|
|Lynch, John||Workgroup member||Astellas Pharmaceuticals, Juno Therapeutics||Advisory/Consultant Role|
|Nori, Priya||Workgroup member||None|
|Ohl, Christopher||Workgroup member||Paratek, Bayer, Cempra Pharmaceuticals||Advisory/Consultant Role|
|Patel, Payal||Workgroup member||None|
|Pottinger, Paul||Workgroup member||McGraw Hill, Elsevier||Honoraria|
|Schwartz, Brian||Workgroup member||None|
|Spicer, Jennifer||Workgroup member||None|
|Stack, Conor||Workgroup member||None|
|Zhou, Yuan||Workgroup member||None|